Updated and New ASCIA Action Plans - 25 June 2018

ASCIA Action Plans for Anaphylaxis and Allergy 2018The Australasian Society for Clinical Immunology and Allergy (ASCIA) has informed Allergy & Anaphylaxis Australia that after an extensive review period, the following 2018 versions of ASCIA Action Plans are now available on the ASCIA website www.allergy.org.au/anaphylaxis :

  • ASCIA Action Plan for Anaphylaxis Personal (RED) Generic version New June 2018

  • ASCIA Action Plan for Anaphylaxis Personal (RED) EpiPen version Updated June 2018

  • ASCIA Action Plan for Anaphylaxis General (ORANGE) Generic version New June 2018

  • ASCIA Action Plan for Anaphylaxis General (ORANGE) EpiPen version Updated June 2018

  • ASCIA Action Plan for Allergic Reactions (GREEN) version Updated June 2018

Please note that although 2018 versions of ASCIA Action Plans are now available, the 2017 or 2016 versions are still valid for use in 2018 if the 'due for review date' is in 2018 or later.

The main changes to the plans (compared to the 2017 versions) are as follows:

  1. New generic versions of ASCIA Action Plans for Anaphylaxis have been developed for use with any brand of adrenaline (epinephrine) autoinjector, with no mention of brand names or brand specific instructions.

  2. Updated EpiPen brand specific versions of ASCIA Action Plans for Anaphylaxis include “How to use EpiPen”. However, to ensure consistency with the generic plans the EpiPen brand name is not mentioned elsewhere.

  3. To reduce the risk of prescribing or dispensing the incorrect dose of adrenaline autoinjector, ASCIA prescribing guidelines are now included on each plan: Adrenaline autoinjectors (300 mcg) are prescribed for children over 20kg and adults; Adrenaline autoinjectors (150 mcg) are prescribed for children 10-20kg.

  4. To minimise the risk of inappropriate treatment and prevent allergic reactions to ticks, the following updated information is included on each plan “For tick allergy seek medical help or freeze tick and let it drop off”.

  5. As a result of new research data, the following wording has been added to each plan “If adrenaline is accidentally injected (e.g. into a thumb) follow this action plan if a person has anaphylaxis and phone your local poisons information centre”. 

Acute Anaphylaxis CSS
Acute Anaphylaxis Clinical Care Standard - Learn more...
Atopic Dermatitis
allergy250K teens/young adults
Food allergy training

Our Supporters

Diamond


Viatris
Sanofi
Nestle
Allergy Concepts

Platinum


  • Bulla
  • NSW Food Authority
  • Novartis
  • Pfizer

Gold


  • dbv technologies
  • Mondelez
  • Nurticia
Silver

  • abbvie
  • Australian Camps Association
  • Bayer
  • Sanctuary Early Learning
  • Sweet William


© 2023 ALLERGY & ANAPHYLAXIS AUSTRALIA
ABN: 70 693 242 620

 



ALLERGY & ANAPHYLAXIS AUSTRALIA
is supported by funding from the
Australian Government,
Department of Health.


ALLERGY & ANAPHYLAXIS AUSTRALIA acknowledges and pays respect to the traditional custodians of the lands on which we work, live and play.

IN AN EMERGENCY

If you are having an allergic reaction follow advice on your ASCIA Action Plan.

If in doubt, give the Anapen® or EpiPen®.

Do not call us for emergency advice.

If you do not have an ASCIA Action Plan and/or an Anapen® or EpiPen® call triple zero (000) for an ambulance.